Can we deliver randomized trials of focal therapy in prostate cancer?-Reference-Cited by-同舟云学术

Can we deliver randomized trials of focal therapy in prostate cancer?

Published:2014-04-22 Issue:8 Volume:11 Page:482-491
ISSN:1759-4774
Container-title:Nature Reviews Clinical Oncology
language:en
Short-container-title:Nat Rev Clin Oncol

Author:

Ahmed Hashim U., ,Berge Viktor,Bottomley David,Cross William,Heer Rakesh,Kaplan Richard,Leslie Tom,Parker Chris,Relton Clare,Stephens Richard,Sydes Matthew R.,Turnbull Lindsay,van der Meulen Jan,Vickers Andrew,Wilt Timothy,Emberton Mark

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://www.nature.com/articles/nrclinonc.2014.44.pdf

Reference88 articles.

1. Wilt, T. J. & Ahmed, H. U. Prostate cancer screening and the management of clinically localized disease. BMJ 346, f325 (2009).

2. Welch, H. G. & Albertsen, P. C. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. J. Natl Cancer Inst. 101, 1325–1329 (2009).

3. Chou, R. et al. Screening for prostate cancer: a review of the evidence for the U. S. preventive services task force. Ann. Intern. Med. 155, 762–771 (2011).

4. McVey, G. P. et al. Initial management of low-risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer Registry. BJU Int. 106, 1161–1164 (2010).

5. Cooperberg, M. R. et al. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J. Clin. Oncol. 22, 2141–2149 (2004).

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomised trials conducted using cohorts: a scoping review;BMJ Open;2024-03

2. Robot-Assisted “Precision” Prostatectomy;Robotic Urology;2024

3. The Trial within Cohorts (TwiCs) study design in oncology: experience and methodological reflections;BMC Medical Research Methodology;2023-05-13

4. Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomes;Cancer Medicine;2023-02-12

5. Median 5‐year outcomes of primary focal irreversible electroporation for localised prostate cancer;BJU International;2022-12-28